Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC
Science 37, a leader in enhancing patient access to clinical trials, has unveiled its new 19,000-square-foot corporate headquarters in Morrisville, North Carolina, within Research Triangle Park. This state-of-the-art facility will serve as a centralized hub for all Science 37 operations, fostering cross-functional collaboration and integrated solution delivery. The move is expected to improve the company's ability to support clinical trial sponsors with greater consistency, speed, and quality in patient recruitment and study conduct.
CEO David Coman emphasized that the relocation not only enhances their operational capabilities but also symbolizes Science 37's commitment to the region and to helping sponsors improve their probability of success in clinical trials. This strategic move reflects the company's recent growth and continued dedication to advancing clinical research accessibility.
Science 37, leader nel migliorare l'accesso dei pazienti alle sperimentazioni cliniche, ha svelato il suo nuovo quartier generale di 19.000 piedi quadrati a Morrisville, nella Carolina del Nord, all'interno del Research Triangle Park. Questa struttura all'avanguardia servirà come un hub centralizzato per tutte le operazioni di Science 37, promuovendo la collaborazione interfunzionale e la consegna integrata di soluzioni. Il trasferimento dovrebbe migliorare la capacità dell'azienda di supportare i promotori di sperimentazioni cliniche con maggiore coerenza, velocità e qualità nella reclutamento dei pazienti e nella conduzione degli studi.
Il CEO David Coman ha sottolineato che il trasferimento non solo potenzia le loro capacità operative, ma simboleggia anche l'impegno di Science 37 verso la regione e il sostegno ai promotori per migliorare le loro probabilità di successo nelle sperimentazioni cliniche. Questa mossa strategica riflette la recente crescita dell'azienda e il suo continuo impegno per avanzare nell'accessibilità alla ricerca clinica.
Science 37, líder en mejorar el acceso de los pacientes a ensayos clínicos, ha revelado su nueva sede corporativa de 19,000 pies cuadrados en Morrisville, Carolina del Norte, dentro del Research Triangle Park. Esta instalación de última generación servirá como un centro centralizado para todas las operaciones de Science 37, promoviendo la colaboración interfuncional y la entrega integrada de soluciones. Se espera que este movimiento mejore la capacidad de la empresa para apoyar a los patrocinadores de ensayos clínicos con mayor consistencia, rapidez y calidad en el reclutamiento de pacientes y en la realización de estudios.
El CEO David Coman enfatizó que la reubicación no solo mejora sus capacidades operativas, sino que también simboliza el compromiso de Science 37 con la región y con ayudar a los patrocinadores a mejorar su probabilidad de éxito en ensayos clínicos. Este movimiento estratégico refleja el reciente crecimiento de la empresa y su continua dedicación a avanzar en la accesibilidad a la investigación clínica.
Science 37는 임상 시험에 대한 환자의 접근성을 높이는 선두주자로서, 노스캐롤라이나 모리스빌에 19,000 평방피트 규모의 새로운 본사를 공개했습니다. 이 최첨단 시설은 Science 37의 모든 운영을 위한 중앙 허브로 기능하며, 기능별 협업과 통합 솔루션 제공을 촉진할 것입니다. 이번 이전은 임상 시험 후원자를 지원하는 회사의 능력을 더욱 일관성 있게, 빠르게, 그리고 품질 높게 개선할 것으로 예상됩니다.
CEO David Coman은 이번 이전이 단순히 운영 능력을 강화하는 것뿐 아니라 Science 37의 이 지역에 대한 헌신을 상징하며, 후원자들이 임상 시험에서 성공할 가능성을 높이는 데 도움을 주고 있다고 강조했습니다. 이 전략적 이동은 회사의 최근 성장과 임상 연구 접근성을 발전시키기 위한 지속적인 헌신을 반영합니다.
Science 37, leader dans l'amélioration de l'accès des patients aux essais cliniques, a découvert son nouveau siège social de 19 000 pieds carrés à Morrisville, en Caroline du Nord, dans le parc de recherche Triangle. Cette installation à la pointe de la technologie servira de centre centralisé pour toutes les opérations de Science 37, favorisant la collaboration interfonctionnelle et la livraison de solutions intégrées. Ce déménagement devrait améliorer la capacité de l'entreprise à soutenir les sponsors d'essais cliniques avec une plus grande cohérence, rapidité et qualité dans le recrutement des patients et la conduite des études.
Le PDG David Coman a souligné que cette relocalisation améliore non seulement leurs capacités opérationnelles, mais symbolise également l'engagement de Science 37 envers la région et l'aide aux sponsors pour améliorer leurs chances de réussite dans les essais cliniques. Ce mouvement stratégique reflète la croissance récente de l'entreprise et son dévouement continu à faire avancer l'accessibilité à la recherche clinique.
Science 37, ein führendes Unternehmen zur Verbesserung des Zugangs von Patienten zu klinischen Studien, hat seinen neuen Unternehmenssitz mit 19.000 Quadratfuß in Morrisville, North Carolina, im Research Triangle Park eröffnet. Diese moderne Einrichtung wird als zentrale Drehscheibe für alle Operationen von Science 37 dienen, die funktionsübergreifende Zusammenarbeit und integrierte Lösungsbereitstellung fördert. Der Umzug soll die Fähigkeit des Unternehmens verbessern, klinische Studien-Sponsoren mit größerer Konsistenz, Geschwindigkeit und Qualität bei der Rekrutierung von Patienten und der Durchführung von Studien zu unterstützen.
CEO David Coman betonte, dass der Umzug nicht nur ihre operationale Leistungsfähigkeit stärkt, sondern auch das Engagement von Science 37 für die Region und die Unterstützung der Sponsoren zur Verbesserung ihrer Erfolgschancen in klinischen Studien symbolisiert. Dieser strategische Schritt spiegelt das jüngste Wachstum des Unternehmens und sein weiterhin bestehendes Engagement für die Verbesserung des Zugangs zur klinischen Forschung wider.
- Expansion to a new 19,000-square-foot corporate headquarters
- Centralization of operations expected to improve efficiency and service quality
- Strategic location in Research Triangle Park, a hub for biotech and pharmaceutical research
- None.
19,000-square-foot facility reflects the company’s recent growth and continued commitment to the region
MORRISVILLE, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, today announced the grand opening of its new, 19,000-square-foot corporate headquarters in Morrisville, North Carolina, in the heart of Research Triangle Park.
The new, state-of-the-art facility, will serve as a hub for all Science 37 operations, enabling cross-functional teams with greater opportunities for collaborative problem-solving and integrated solution delivery. Centralizing operations in one facility will enable Science 37 to deliver patient recruitment and study conduct support on behalf of clinical trial sponsors with greater consistency, speed, and quality.
When asked about relocating to their new offices, Science 37 Chief Executive Officer, David Coman, stated, “Practically speaking, we’re better situated than ever to help our sponsors navigate the challenges of recruiting, enrolling, and treating difficult-to-reach patient populations. Symbolically, this move is just as important. It demonstrates our commitment to the region and to helping our sponsors improve their probability of success.”
To learn more about the Science 37, please visit www.science37.com.
About Science 37
Science 37’s mission is to accelerate clinical research by enabling universal trial access for patients. Through our solutions; the Metasite™ and Patient Recruitment, we accelerate enrollment by expanding the reach of clinical trials to patients beyond the traditional site and rigorously qualifying patients prior to referring them to a traditional site. Our solutions are powered by a proprietary technology stack with in-house medical and operational experts that enhance quality through standardized workflows and best-in-class study orchestration. To learn more, visit www.science37.com, or email science37@science37.com.
To view studies that Science 37 is actively recruiting for, please visit https://studies.science37.com/current-studies.
Media Inquiries
Science 37
PR@science37.com
FAQ
Where is Science 37's new corporate headquarters located?
How large is Science 37's new headquarters facility?
What benefits does Science 37 expect from its new headquarters?
What did Science 37's CEO say about the new headquarters?
